ASSOCIATION FOR MULTIPLE ENDOCRINE NEOPLASIA DISORDERS

Registered charity 1153890 · accounts filings on the Charity Commission register · also known as AMEND

AMEND PROVIDES SUPPORT AND INFORMATION TO PATIENTS FAMILIES AND CARERS AFFECTED BY THE RARE GENETIC DISORDERS MULTIPLE ENDOCRINE NEOPLASIA, AS WELL AS TO THOSE WITH ASSOCIATED FAMILIAL AND SPORADIC TUMOURS. AMEND AIMS TO PROMOTE GREATER KNOWLEDGE OF THE BEST CARE AND MANAGEMENT OF MEN AND ASSOCIATED TUMOUR PATIENTS AMONGST THE MEDICAL PROFESSION.

Causes: The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Financial health, per its FY2024 accounts

The accounts state that the charity ended the year with a deficit of £10,843, a significant improvement from the £31,624 deficit in the previous year. Per the trustees' report, unrestricted reserves increased to £76,915, which is above the stated policy target of £60,000. The trustees confirm there are no material uncertainties regarding the charity's ability to continue as a going concern.

Automated summary of the FY2024 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Public profiles (found on the charity’s own website): facebook

Trustees · trustee networks

• Andrew Price
• Dr John Ayuk
• GILL MASTERS
• Graeme Cohen
• Lauren Wheeler ACA
• Miriam Asia
• PROFESSOR KARIM MEERAN
• Robert Millinship
• Sarah Norman
• Shahab Khan

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Common questions

Government & lottery funding

Grants to this charity published as open data by government and lottery funders (360Giving).